The Chief Medical Officer (CMO) of US-based Moderna Inc. (NASDAQ: MRNA), Paul Burton, has been reported as saying that the company is “eager” to bring its mRNA-based COVID-19 vaccines to China. According to sources, Moderna’s chief executive Stephane Bancel disclosed last week that the company has engaged in talks with the Chinese government regarding the supply of vaccines, though no concrete decisions have been made yet.
CMO’s Statement and Future Outlook
As quoted by the source, Burton told a media briefing: “We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there,” although he also noted: “Currently, there is no activity going on, but we’d be very open to it.” This statement underscores Moderna’s interest in expanding its reach into the Chinese market, where the demand for advanced COVID-19 vaccines remains significant.-Fineline Info & Tech
